 Avadel Pharmaceuticals plc NASDAQ:AVDL Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Brandi Robinson - Senior Vice President of Corporate Affairs Douglas Williamson - Chief Medical Officer Gregory Divis - Chief Executive Officer Jennifer Gudeman - Vice President of Medical Clinical Affairs Richard Kim - Chief Commercial Officer Tom McHugh - Senior Vice President Chief Financial Officer Conference Call Participants Francois Brisebois - Oppenheimer Marc Goodman - SVB Securities Oren Livnat - H.C. Wainwright Matt Kaplan - Laddenburg Robin Garner - Craig Hallum Adam Evertts - LifeSci Capital Operator Ladies and gentlemen, thank you for standing by and welcome to the Avadel Pharmaceuticals First Quarter 2022 Earnings Call. 